Skip to content

Effect of cyclopofol injection on memory and sleep quality of senile patients after painless gastroenteroscopy

Effect of cyclopofol injection on memory and sleep quality of senile patients after painless gastroenteroscopy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100055026
Enrollment
Unknown
Registered
2021-12-30
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:cyclopofol injection
Group 2:propofol

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 65-80 years, gender is not limited; 2. American Anesthesiologist Classification (ASA) I-III; 3. Elderly patients undergoing painless gastroscopy and/or colonoscopy in outpatient clinics; 4. Diagnosis and treatment time=10 and =95% when breathing air; systolic blood pressure (SBP) >=90mmHg and =60mmHg and =55 and <=100 beats/min; 7. Be able to understand the research process and method, and voluntarily participate in this research.

Exclusion criteria

Exclusion criteria: 1. Those with contraindications to general anesthesia or those who have had a history of anesthesia accident in the past; 2. There is sleep disorder before the examination, PSQI<=5; 3. Alzheimer's disease or cognitive impairment; 4. Known or suspected allergies or contraindications to propofol injection, cyclopofol injection excipients, opioids, etc.; 5. Subjects with acute upper respiratory tract infection, asthma attack or acute severe laryngeal disease; 6. There is a history of gastrointestinal disease: gastrointestinal retention, active bleeding, which may lead to reflux and aspiration; 7. Combined with craniocerebral injury, intracranial hypertension, stroke, unstable angina, myocardial infarction, heart failure; uncontrolled diabetes or hypertension; severe liver dysfunction or severe renal insufficiency; 8. Respiratory insufficiency, obstructive pulmonary disease, difficult airway or judged to be difficult for endotracheal intubation (modified Markov score is grade III or grade IV); 9. History of alcoholism or drug dependence; 10. Abuse or long-term use of narcotic, sedative and analgesic drugs; 11. Those who have a history of mental illness in the past; 12. Those who have participated in any drug clinical trials within 1 month before screening; 13. Subjects who are considered by the investigator to have any other factors that are not suitable for participating in this trial.

Design outcomes

Primary

MeasureTime frame
Anterior retrospective memory questionnaire;

Countries

China

Contacts

Public ContactYang Pingliang
yangpingliang@126.com+86 18140064602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026